Va calc spice bath salts 2011 04-14 final
Upcoming SlideShare
Loading in...5
×
 

Va calc spice bath salts 2011 04-14 final

on

  • 505 views

VA Bath salts

VA Bath salts

Statistics

Views

Total Views
505
Slideshare-icon Views on SlideShare
505
Embed Views
0

Actions

Likes
0
Downloads
12
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • No disclosure
  • Potpouri, other brands
  • Also vaporization, many mix due to the poor taste, ads such as above look more like MJ than in reality Poorly labeled contents John Huffman compounds, Pfizer CP compound, 100s of others
  • Potency: tigher binding, full agonism: potentially greater harm?
  • Virtually nothing known about clinical effects (e.g., from human lab studies), few non-structured studies describe Also, MJ cas >60 cannabinoids may modulate delta-9 effects (e.g., cannabidiod) Survey data
  • Acute anxiety reactions, psychosis in biol vulnerable
  • Available in UK 2006-7 first mention Off the shelves 12/2010 before xmas still available INTERNET REG? CHANGE NAME? COMPOUND?
  • Anecdotally teen/young adult National Poison Data System (NPDS
  • Limited data on clinical effects, mostly non-scientific anecdote
  • MDMA comparison anecdotal, non-scietific data hence slang terminology
  • Also, few scientific data
  • Anecdotally teen/young adult National Poison Data System (NPDS

Va calc spice bath salts 2011 04-14 final Va calc spice bath salts 2011 04-14 final Presentation Transcript

  • Synthetic Drugs of Abuse: ‘Spice,’ ‘K2’ and ‘Bath Salts’ Erik Gunderson, MD Assistant Professor Department of Psychiatry and Neurobehavioral Sciences and Department of Medicine Director, Clinical Pharmacological Research Unit University of Virginia April 14, 2011
  • Synthetic Cannabinoids (SCs)
    • Spice/K2 brands marketed as natural herbal incense
    • “ Not for human consumption”
    • Available convenience stores, gas stations, Internet
    • Cannabis substitute
    Psychonaut Web Mapping Research Group (2009.) Spice Report. Institute of Psychiatry, King’s College London: London UK.
  •  
  • Spice and K2
    • Cost : $30-45 per 3gm
    • Route : pipes, water pipes or rolled cigarettes
    • Contents : inert plant material sprayed with SCs
      • JWH-018, JWH-073, JWH-250, CP-47,497, HU-210
    http://buyherbalspice.com/spice_reviews/category/news/
  • Pharmacology
    • delta-9 tetrahydro-cannabinol (∆ 9 -THC) agonism of cannabinoid receptor type 1 (CB1)
    • SCs more potent
    • Typical doses are often less than 1mg
    • Not readily detectable
    JWH-018 ∆ 9 -THC
  • Psychoactive Effects
    • Marketed as similar to cannabis:
    • Euphoria
    • Sociability
    • Anxiolytic
    • Relaxation
    • Stimulant
    • Cross tolerance with THC?
    http://buyk2spice.net/
  • Side Effects of SC Products
    • Anxiety
    • Paranoia
    • Headache
    • Vomiting
    • Psychosis
    • Diaphoresis
    • HR/BP increase
    • Seizures
    http://investigationmiami.blogspot.com/2011/01/be-afraid-really-afraid.html
  • Legal Timeline for SCs
    • 2009 : Restricted in the UK, EU
    • 11/2010 : DEA Notice of Intent to temporarily ban 5 SCs
    • 3/1/2011 : Five SCs Designated Schedule I
      • JWH-018, JWH-073, JWH-200, CP-47,497, and cannabicyclohexanol
      • Effective for one year
  • Current and Future Epidemiology?
    • No data on prevalence of use
    • American Association of Poison Control Centers:
    • Synthetic cannabinoids:
      • 2009: 13 calls
      • 2010: 2304 calls (Nov), a projected 200x increase
      • Marijuana:
      • 2008: 4009 calls, with 1020 for marijuana alone
  • Synthetic Stimulants
    • Methylenedioxypyrovalerone (MDPV) and Mephedrone
      • Sold as “bath salts” or “plant fertilizer”
    • Currently legal in the United States
    • Available online and in convenience stores
  • MDPV and Mephedrone
    • CNS stimulants
    • Related to cathinone, an active alkaloid found in the khat plant (N. Africa)
    • Previously abused
    • primarily in
    • Europe and
    • Australia
    http://www.herbalextracts.net/library/supplements/khat_uses.html
  • Product Marketing
    • Mtv
    • MDPK
    • Magic
    • Super Coke
    • Peevee
    • Energy-1 (NRG1)
    • Charge Plus
    • White Lightning
    • Scarface
    • Cloud 9
    • Ocean
    • Ivory Wave
    http://www.helphopehealing.org/
  • MDPV
    • Route: Intranasal most common
    • Also: oral, smoking, rectal, and IV
    • White to light brown crumbly powder
    • Degrades if exposed to air for significant periods of time
    http://www.stompin-gardeners.com/index. MDMA
  • Pharmacology of MDPV
    • CNS stimulant similar to methamphetamine, MDMA, or cocaine
    • Norepinephrine-dopamine reuptake inhibitor (NDRI)
    • Increased alertness, arousal, anxiety, agitation, diminished requirement for food and sleep, sexual arousal
    • Tachycardia, hypertension, vasoconstriction, diaphoresis
  • Effects of MDPV
    • “ High” lasts 3-4 hours
    • Physical effects may last 6-8 hours
    • May cause seizures, panic attacks, or psychosis with high doses or increased frequency of use
    • Avg dose: 5 to 20mg
    http://www.tradevv.com/chinasuppliers/chwhtltd_p_198b58/china-Mdpv-by-pevukka.html
  • Other Sequelae of MDPV
    • Trismus (inability to open mouth) or bruxism
    • Panic attacks
    • Psychosis with sleep deprivation
    • Hallucinations, delusions, suicidal ideation
    • Abstinence syndrome: depression, lethargy, anxiety, postural hypotension
      • Leads to frequent re-dosing
  • MDPV’s Legal Status
    • UK: MDPV regulated under the Misuse of Drugs Act 1971
    • US: Not scheduled but banned in some states
    • DEA: controlled by the Federal Analogue Act?
    http://addiction-dirkh.blogspot.com/2010/11/dea-slaps-temporary-ban-on-spice-and.html
  • Mephedrone
    • 4-methylmethcathinone (4-MMC)
    • Meow Meow
    • MCAT
    • Miaow
    • Drone
    • Plant Feeder
    • Bubbles
    http://www.synchronium.net/2010/01/05/mephedrone-cat/
  • Pharmacology
    • NE-DA reuptake inhibitor
    • Similar to MA/MDMA
      • Reportedly less potent, shorter duration
    • Oral dose: 20-50mg
    • “ Come up”: 10-20 min
    • Peak: 45-60 min
    • “ Comedown”: 60-120 min
    • Re-dosing: common
    Mephedrone Amphetamine
  • Routes of Administration
    • Oral ingestion
      • Swallowing capsules
      • Bombing (swallowing powder wrapped in cigarette paper)
    • Insufflation (snorting)
    • Rectally (either plugging or enema)
    • IV (use 1/2 to 1/3 dose)
    http://www.guardian.co.uk/society/mephedrone
  • Effects of Mephedrone
    • Euphoria
    • Sociability
    • Stimulation
    • Sexual Arousal
    • Music Appreciation
    • Hallucinations
    http://www.drugs.org.im/campaigns.htm
  • Mephedrone Side Effects
    • Loss of appetite
    • Increase in body temperature, sweating, hot flushes
    • Tense jaw, bruxism, stiff neck, muscle clenching
    • HR/BP elevation, chest pains
    • Dehydration
    • Mydriasis, nystagmus
    • Painful nasal drip/ulcers in mouth (after insufflation)
    • Insomnia, paranoia, anxiety, dysphoria, psychosis
    http://theblackheartofgrahamquirk.blogspot.com/
  • Mephedrone’s Legal Status
    • 2008-2010: Banned in many European counties
    • December 2010: Illegal throughout the EU
    • Mephedrone is not specifically banned in the United States
      • However, some states have banned mephedrone
    • DEA: may be controlled by the Federal Analogue Act as an analogue of methcathinone
  • Current and Future Epidemiology?
    • No data on prevalence of use
    • American Association of Poison Control Centers:
    • Bath Salts:
      • 2010: 292 calls
      • 2011: 469 calls (2/14/11), a projected14-fold increase
  • Questions?
  • References
    • Brunt, T.; Poortman, A.; Niesink, R.; Van Den Brink, W. (2010). "Instability of the ecstasy market and a new kid on the block: mephedrone". Journal of psychopharmacology .
    • Drug Enforcement Administration: Office of Diversion Control; Drug and Chemical Evaluation Section. Methylenedioxypyrovalerone [(MDPV) (1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone]. Available at: www.deadiversion.usdoj.gov/drugs_concern/mdpv.pdf. Accessed February 7, 2011.
    • EMCDDA (2009). Action on new drugs briefing paper: Understanding the ‘spice’ phenomenon. A report from an EMCDDA expert meeting, 6 March, 2009, Lisbon.
    • "Europol - MCDDA Joint Report on a new psychoactive substance: 4-methylmethcathinone (mephedrone)". European Monitoring Centre for Drugs and Drug Addiction. 27 May 2010.
    • Psychonaut WebMapping Research Group (2009). MDPV report. Institute of Psychiatry, King’s College London: London UK. Available at: www.nascsa.org/news/psychonautmdpvreport.pdf . Accessed February 23, 2011.
    • Psychonaut WebMapping Research Group (March 2010). "Mephedrone Report." Institute of Psychiatry, King's College: London UK.
    • Psychonaut Web Mapping Research Group (2009.) Spice Report. Institute of Psychiatry, King’s College London: London UK.
    • United States Drug Enforcement Agency. Office of Diversion Control. Drugs and Chemical of Concern: 4-methylmethcathinone [Mephedrone, 4-MMC, meow meow, m-CAT, bounce, bubbles, mad cow]. July 2010.
    • United States Drug Enforcement Agency. Office of Diversion Control. Rules 2011: Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids Into Schedule I. Federal Register Volume 76, Number 40 (Tuesday, March 1, 2011).
    • Wehrman J. U.S. Poison Centers Raise Alarm about Toxic Substance Marketed as Bath Salts; States Begin Taking Action. AAPCC. February 14, 2011. Available at: http://www.aapcc.org/dnn/Portals/0/prrel/FEB14BATHSALTSUSE.pdf
    • Winstock, A.; Mitcheson, L.; Deluca, P.; Davey, Z.; Corazza, O.; Schifano, F. (2010). "Mephedrone, new kid for the chop?". Addiction 106 (1).
  • Acknowledgement Laura Willing, BS Contact Information Erik Gunderson, MD 434-924-8013 office [email_address]